We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+5.47%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
AUM
$6.89B
AUM Growth
-$226M
Cap. Flow
-$560M
Cap. Flow %
-8.14%
Top 10 Hldgs %
12.13%
Holding
2,170
New
136
Increased
1,113
Reduced
460
Closed
437

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$7.72M
2
JNJ icon
Johnson & Johnson
JNJ
+$7.46M
3
NVS icon
Novartis
NVS
+$6.93M
4
PG icon
Procter & Gamble
PG
+$6.45M
5
T icon
AT&T
T
+$5.65M

Sector Composition

Rank Sector Weight
1 Financials 17.12%
2 Technology 13.7%
3 Healthcare 13.69%
4 Energy 10.43%
5 Industrials 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKT icon
1026
Tanger
SKT
$4.09B
$621K 0.01%
17,771
+464
+3% +$16.5K
SLXP
1027
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$619K 0.01%
5,017
+709
+16% +$78.4K
LII icon
1028
Lennox International
LII
$12.5B
$618K 0.01%
6,903
+458
+7% +$39.8K
MED icon
1029
Medifast
MED
$134M
$618K 0.01%
20,317
+1,125
+6% +$35.1K
JNS
1030
DELISTED
Janus Capital Group Inc
JNS
$618K 0.01%
49,558
+291
+0.6% +$3.42K
NWN icon
1031
Northwest Natural Holdings
NWN
$2.04B
$615K 0.01%
13,046
-1,744
-12% -$78.1K
GAME
1032
DELISTED
SHANDA GAMES LTD SPON ADR REPSTG CL A (CAYMAN ISLANDS)
GAME
$614K 0.01%
92,421
+80,178
+655% +$534K
CSGP icon
1033
CoStar Group
CSGP
$12.3B
$613K 0.01%
38,730
+3,080
+9% +$49.9K
G icon
1034
Genpact
G
$5.89B
$613K 0.01%
34,951
+5,962
+21% +$102K
BDC icon
1035
Belden
BDC
$4.39B
$608K 0.01%
7,777
+35
+0.5% +$2.57K
RYN icon
1036
Rayonier
RYN
$5.95B
$608K 0.01%
18,836
-3,612
-16% -$113K
VIA
1037
DELISTED
Viacom Inc. Class A
VIA
$607K 0.01%
7,002
+84
+1% +$7.15K
R icon
1038
Ryder
R
$9.09B
$606K 0.01%
6,875
+1,827
+36% +$153K
RDC
1039
DELISTED
Rowan Companies Plc
RDC
$604K 0.01%
18,932
+1,613
+9% +$50.5K
BMR
1040
DELISTED
BIOMED REALTY TRUST INC
BMR
$604K 0.01%
27,687
+5,559
+25% +$118K
ARCC icon
1041
Ares Capital
ARCC
$13.8B
$603K 0.01%
33,789
-11,614
-26% -$200K
ATI icon
1042
ATI
ATI
$25.6B
$603K 0.01%
13,374
+740
+6% +$30.3K
THC icon
1043
Tenet Healthcare
THC
$21.3B
$603K 0.01%
12,838
+5,032
+64% +$227K
GRA
1044
DELISTED
W.R. Grace & Co.
GRA
$602K 0.01%
6,367
-1,330
-17% -$125K
TUP
1045
DELISTED
Tupperware Brands Corporation
TUP
$600K 0.01%
7,173
+291
+4% +$24.5K
VVC
1046
DELISTED
Vectren Corporation
VVC
$599K 0.01%
14,099
+1,283
+10% +$51.3K
CVI icon
1047
CVR Energy
CVI
$5.36B
$598K 0.01%
12,417
+2,697
+28% +$127K
FDS icon
1048
Factset
FDS
$9.75B
$598K 0.01%
4,968
-28
-0.6% -$3.04K
ICLR icon
1049
Icon
ICLR
$13.4B
$596K 0.01%
12,641
+102
+0.8% +$4.41K
LPNT
1050
DELISTED
LifePoint Health, Inc.
LPNT
$596K 0.01%
9,597
+590
+7% +$34.6K

Similar funds

Aperio Group's Q2 2014 Portfolio in Review

As of Q2 2014, Aperio Group held 2,170 positions worth $6.89B, down 3.2% from $7.11B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Aperio Group withdrew a net $560M in Q2 2014, closing 437 positions and reducing 460 holdings. Its most notable exit was BASF AKTIENGESELLT ADS(RP1 ORD, an estimated $19M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Aperio Group opened a new position in Brookfield Property Partners L.P. Limited Partnership Units worth $2.28M.

  • Aperio Group's largest Q2 2014 buy was Brookfield Property Partners L.P. Limited Partnership Units: 109,335 shares worth $2.28M.
  • Aperio Group added most to Apple in Q2 2014, an estimated $7.72M increase.
  • Aperio Group's biggest Q2 2014 reduction was ETABLISSEMENT DELHZ ADS 4 ADS REPTGS 1 ORD SHS, cutting an estimated $15.8M.
  • Aperio Group fully exited BASF AKTIENGESELLT ADS(RP1 ORD in Q2 2014, selling an estimated $19M.
  • Aperio Group's ten largest holdings make up 12% of its $6.89B portfolio in Q2 2014.
  • Aperio Group opened 136 new positions and closed 437 in Q2 2014.
  • Aperio Group's portfolio value fell 3.2% quarter-over-quarter to $6.89B.

Based on Aperio Group's 13F filing for Q2 2014, filed 23 Jul 2014.